These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12356596)

  • 1. Complementary or alternative? Stronger vs weaker integration policies.
    Hess DJ
    Am J Public Health; 2002 Oct; 92(10):1579-81. PubMed ID: 12356596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New opportunities and proven approaches in complementary and alternative medicine research at the National Institutes of Health.
    Harlan WR
    J Altern Complement Med; 2001; 7 Suppl 1():S53-9. PubMed ID: 11822636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research on complementary and alternative medicine using randomized controlled trials.
    Harlan WR
    J Altern Complement Med; 2001; 7 Suppl 1():S45-52. PubMed ID: 11822635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.
    Kantor M
    J Am Coll Radiol; 2009 Apr; 6(4):254-62. PubMed ID: 19327658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCCAM support for the Cochrane Collaboration CAM Field.
    Manheimer E; Berman B
    Complement Ther Med; 2003 Dec; 11(4):268-71. PubMed ID: 15022665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary and alternative medicine research: a National Cancer Institute perspective.
    White JD
    Semin Oncol; 2002 Dec; 29(6):546-51. PubMed ID: 12516037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The National Cancer Institute's perspective and agenda for promoting awareness and research on alternative therapies for cancer.
    White JD
    J Altern Complement Med; 2002 Oct; 8(5):545-50. PubMed ID: 12470434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Science and government. Enhanced: in defense of NCCAM.
    Straus SE; Chesney MA
    Science; 2006 Jul; 313(5785):303-4. PubMed ID: 16857924
    [No Abstract]   [Full Text] [Related]  

  • 10. CAM research in Britain: the last 10 years.
    Ernst E; Schmidt K; Wider B
    Complement Ther Clin Pract; 2005 Feb; 11(1):17-20. PubMed ID: 15984219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary and alternative therapeutics: rigorous research is needed to support claims.
    Kinsel JF; Straus SE
    Annu Rev Pharmacol Toxicol; 2003; 43():463-84. PubMed ID: 12540748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racing toward the integration of complementary and alternative medicine: a marathon or a sprint?
    Nahin RL; Pontzer CH; Chesney MA
    Health Aff (Millwood); 2005; 24(4):991-3. PubMed ID: 16012139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAM research and development.
    Lewith G; Holgate S
    Complement Ther Nurs Midwifery; 2000 Feb; 6(1):19-24. PubMed ID: 11033649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary/alternative medicine and cancer research. A national initiative.
    Richardson MA; White JD
    Cancer Pract; 2000; 8(1):45-8. PubMed ID: 10732539
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of complementary medicine by adult patients participating in cancer clinical trials.
    Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
    Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blending the boundaries: steps toward an integration of complementary and alternative medicine into mainstream practice.
    Giordano J; Boatwright D; Stapleton S; Huff L
    J Altern Complement Med; 2002 Dec; 8(6):897-906. PubMed ID: 12614540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAM evaluation comes into the mainstream: NIH specialized Centers of research and the University of Maryland Center for Alternative Medicine Research in Arthritis.
    Berman BM; Hartnoll S; Bausell B
    Complement Ther Med; 2000 Jun; 8(2):119-22. PubMed ID: 10859605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Science and government. Review for NCCAM is overdue.
    Marcus DM; Grollman AP
    Science; 2006 Jul; 313(5785):301-2. PubMed ID: 16857923
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging complementary and alternative medicine policy initiatives and the need for dialogue.
    Knox KE; Fønnebø V; Falkenberg T
    J Altern Complement Med; 2009 Sep; 15(9):959-62. PubMed ID: 19697994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studying complementary and alternative therapies.
    Offit PA
    JAMA; 2012 May; 307(17):1803-4. PubMed ID: 22550193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.